Efficient generation of recombinant influenza A viruses employing a new approach to overcome the genetic instability of HA segments

PLoS One. 2015 Jan 23;10(1):e0116917. doi: 10.1371/journal.pone.0116917. eCollection 2015.

Abstract

Influenza A viruses (IAVs) are the most relevant and continual source of severe infectious respiratory complications in humans and different animal species, especially poultry. Therefore, an efficient vaccination that elicits protective and neutralizing antibodies against the viral hemagglutinin (HA) and neuraminidase (NA) is an important strategy to counter annual epidemics or occasional pandemics. With the help of plasmid-based reverse genetics technology, it is possible that IAV vaccine strains (IVVS) are rapidly generated. However, the genetic instability of some cloned HA-cDNAs after transformation into competent bacteria represents a major obstacle. Herein, we report efficient cloning strategies of different genetically volatile HA segments (H5- and H9-subtypes) employing either a newly constructed vector for reverse genetics (pMKPccdB) or by the use of the Escherichia coli strain HB101. Both approaches represent improved and generalizable strategies to establish functional reverse genetics systems preventing genetic changes to the cloned (HA) segments of IAV facilitating more efficient rescue of recombinant IAV for basic research and vaccine development.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Cloning, Molecular / methods*
  • Dogs
  • Genetic Vectors / genetics
  • HEK293 Cells
  • Hemagglutinin Glycoproteins, Influenza Virus / genetics*
  • Humans
  • Influenza A virus / genetics*
  • Madin Darby Canine Kidney Cells
  • Mutagenesis, Site-Directed
  • Neuraminidase / genetics*
  • Recombinant Proteins / genetics
  • Viral Proteins / genetics
  • Viral Proteins / metabolism

Substances

  • Hemagglutinin Glycoproteins, Influenza Virus
  • Recombinant Proteins
  • Viral Proteins
  • Neuraminidase

Grants and funding

This work was supported in part by the FluResearchNet, “Molecular Signatures Determining Pathogenicity and Species Transmission of Influenza A Viruses”, funded by the German Federal Ministry of Education and Research (BMBF, grant 01 KI 1006E, to S. P. and grant, 01 KI 1006D to S. R.) and by a fellowship of the German-Egyptian Research Long-Term Scholarship “GERLS” program co-funded by the Egyptian government and the German Academic Exchange Service (DAAD, to A. M.). This work was also supported by a fellowship of the Egyptian Science and Technology Development Fund (STDF, to S. I.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.